Stay updated with breaking news from Membrane Type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) insider Nigel Crockett sold 2,643 shares of the firm’s stock in a transaction on Wednesday, January 3rd. The shares were sold at an average price of $17.50, for a total value of $46,252.50. Following the sale, the insider now directly owns 48,716 shares in the company, valued […]
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) saw a large drop in short interest in the month of November. As of November 15th, there was short interest totalling 4,000,000 shares, a drop of 8.5% from the October 31st total of 4,370,000 shares. Based on an average daily trading volume, of 434,300 shares, the short-interest […]
/PRNewswire/ -- The "China Membrane Bioreactor Market, Competition, Forecast & Opportunities, 2028" report has been added to ResearchAndMarkets.com's offering....
FABR (Film Bulk Acoustic Resonator) Filter Market Analysis and Future Prospects for 2030
Cantor Fitzgerald restated their overweight rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a research note released on Wednesday, Benzinga reports. Cantor Fitzgerald currently has a $65.00 target price on the stock. A number of other brokerages have also issued reports on BCYC. B. Riley raised Bicycle Therapeutics from a neutral rating […]